Antitumour effects of Corynebacterium parvum in mice.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000401:mortality*; D003352:Corynebacterium / Q000276:immunology*; D003354:Corynebacterium Infections / Q000276:immunology*; D007111:Immunity, Cellular; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D010587:Phagocytosis; D011425:Propionibacterium acnes / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000276:immunology / Q000401:mortality*; D013154:Spleen / Q000502:physiology; D013950:Thymus Gland / Q000502:physiology; D013997:Time Factors